Search Results
Apr 21, 2026, 03:43 ET RoboSense Unveiled EOCENE SPAD-SoC Architecture and Chipsets Phoenix and Peacock: Ushering the LiDAR Industry into the Image-grade Era of High-Definition 3D Perception
https://www.dropbox.com/scl/fo/zafeavobmdke8cp0mgmtt/AKduk648136gxk3w9moF87o?rlkey=5n0n2843o5hpvqgm0fxmi2q9t&st=nagfu804&dl=0About RoboSenseRoboSense (02498 HKEX) is an AI-driven robotics
More news about: RoboSense Technology Co., Ltd.
Apr 21, 2026, 02:01 ET Equiduct Launches US Stocks Trading Segment, Bringing Commission-Free On-Exchange Access to US Equities for European Retail Brokers
SIX x-clear and Cboe Clear appointed as interoperable clearing counterparties for the new segment, with DTCC T+1 settlement.LONDON, April 21, 2026 /PRNewswire/ -- Equiduct, Europe's leading pan-European retail-focused
More news about: Equiduct
Apr 21, 2026, 02:01 ET Equiduct Launches US Stocks Trading Segment, Bringing Commission-Free On-Exchange Access to US Equities for European Retail Brokers
SIX x-clear and Cboe Clear appointed as interoperable clearing counterparties for the new segment, with DTCC T+1 settlement.LONDON, April 21, 2026 /PRNewswire/ -- Equiduct, Europe's leading pan-European retail-focused
More news about: Equiduct
Apr 21, 2026, 02:00 ET Seeing Machines Releases Part 2 of Technical Paper Series on Intoxication
E: [email protected] T: +61 419 149 683
More news about: Seeing Machines Limited
Apr 21, 2026, 02:00 ET Seeing Machines Releases Part 2 of Technical Paper Series on Intoxication
Contact: E: [email protected] T: +61 419 149 683Logo - https://mma.prnewswire.com/media/1247670/5927608/Seeing_Machines_Logo_Logo.jpg
More news about: Seeing Machines Limited
Apr 20, 2026, 22:54 ET Cadonilimab Combination Demonstrates Promising Survival Benefit in Locally Advanced Pancreatic Cancer: Phase II COMPASSION-26 Data Presented at AACR 2026
innovation ecosystem centered on its Tetrabody antibody technology platform, AI-powered drug R&D platform, Dual-Shield ADC technology platform, Dual-Lock T-cell engager (TCE) technology platform, Tissue-Smart siRNA/mRNA technology platform, and cell therapy technology platforms. Supported by a global-standard
More news about: Akeso, Inc.
Apr 20, 2026, 22:00 ET Mabwell Passes On-site GMP Inspection by Regulatory Authority of PIC/S Member Country (Jordan) for the First Time
Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that its wholly-owned subsidiary, T-mab, has successfully passed the on-site GMP inspection conducted by the Jordan Food and Drug Administration (JFDA). The inspection covered two denosumab
More news about: Mabwell
Apr 20, 2026, 16:01 ET Nektar Therapeutics Announces Proposed Public Offering
autoimmune and chronic inflammatory diseases. Nektar's lead product candidate, rezpegaldesleukin (REZPEG, or NKTR-358), is a novel, first-in-class regulatory T cell stimulator being evaluated in one Phase 2b clinical trial in atopic dermatitis, one Phase 2b clinical trial in alopecia areata, and in one Phase
More news about: Nektar Therapeutics
Apr 20, 2026, 13:15 ET Verismo Therapeutics' Initial Clinical Data from STAR-101 Phase 1 Trial of SynKIR™-110 KIR-CAR Presented at AACR 2026 Plenary Session
derived from natural killer cells, designed to drive long-term anti-tumor T cell function without T cell exhaustion. By keeping antigen recognition separate from T cell activation, the multi-chain architecture is intended to sustain T cell activity even in challenging solid-tumor microenvironments.The
More news about: Verismo Therapeutics
Apr 20, 2026, 11:30 ET Silver Deficit Hits Sixth Straight Year as One Cobalt Camp Consolidator Prepares to Drill the Boundaries Past Producers Could Never Cross
tonnes grading 47.5 g/t Ag for approximately 2,960,000 contained ounces of silver (GeoVector Management, 2011, based on 764 drill holes totalling 3,012 metres).¹[4] Core-area programs have returned higher grades — Temex's 2012 re-sampling reported a historical average of 60.9 g/t silver for the North
More news about: USA News Group
Apr 20, 2026, 11:30 ET Visible Things Supercharges the Superfan Economy with Quickplay's AI Studio and Content to Value Operating System
ad impressions served and 99.999% streaming uptime. Quickplay was founded by four innovators with deep media and entertainment technology experience from AT&T, McKinsey and Company, The Walt Disney Company, and Warner Bros. Discovery.Headquartered in Toronto, the company has offices in Los Angeles,
More news about: Quickplay
Apr 20, 2026, 10:51 ET St. David's South Austin Medical Center first in world to enroll patient in clinical trial evaluating a next-generation treatment for aggressive large B-cell lymphoma
rondecabtagene autoleucel (ronde-cel), which builds on the promise of CAR T-cell therapy—a treatment that aims to reprogram a patient's own immune cells to better recognize and attack cancer. Unlike traditional treatments, CAR T-cell therapy is more personalized and has transformed how some blood cancers
More news about: St. David's South Austin Medical Center
Apr 20, 2026, 10:30 ET L'e-ATAK autonome de Karsan est devenu l'une des premières applications de transport public autonome dans le domaine du tourisme à ski !
désormais partie intégrante de la vie réelle. Ce nouveau succès renforce encore le leadership de Karsan dans le domaine de la mobilité autonome », a-t-il déclaré.
More news about: KARSAN OTOMOTİV SAN.VE TİC.A.Ş.
Apr 20, 2026, 10:00 ET AACR 2026 Oral Presentation: Abogen Presents Preliminary Results of ABO2203 (mRNA-Encoded CD3×CD19 TCE) from First-in-Human Clinical Study in R/R B-NHL
Shanghai Jiao Tong University School of Medicine. ABO2203 is a lipid nanoparticle (LNP)-formulated mRNA drug candidate encoding a CD3×CD19 bispecific T-cell engager (TCE). By enabling in vivo TCE expression via mRNA, ABO2203 is designed to mitigate cytokine release syndrome (CRS)
More news about: Abogen
Apr 20, 2026, 10:00 ET AACR 2026 Oral Presentation: Abogen Presents Preliminary Results of ABO2203 (mRNA-Encoded CD3×CD19 TCE) from First-in-Human Clinical Study in R/R B-NHL
Shanghai Jiao Tong University School of Medicine. ABO2203 is a lipid nanoparticle (LNP)-formulated mRNA drug candidate encoding a CD3×CD19 bispecific T-cell engager (TCE). By enabling in vivo TCE expression via mRNA, ABO2203 is designed to mitigate cytokine release syndrome (CRS)
More news about: Abogen
Apr 20, 2026, 09:30 ET Myasthenia Gravis Foundation of America Launches MGFA Food Support Program to Advance Nutrition Access and Health Equity for Individuals with Myasthenia Gravis
[email protected] +1-617-610-2411UCB Contact Information:Daphne Teo U.S. Communications T +1.770.880.7655 [email protected]
More news about: Myasthenia Gravis Foundation of America, Inc.
Apr 20, 2026, 09:08 ET MIAMI REALTORS® and RWorld Announce Merger
T3 Sixty 2025 MLS rankings.When formed, the Miami and South Florida REALTORS® Beaches MLS will be the largest MLS owned by one U.S. Realtor association.
More news about: MIAMI Association of REALTORS®
Apr 20, 2026, 09:05 ET First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries
Mortality Risk. The Lancet. Infectious diseases, 21(2), pp.241–251. DOI: 10.1016/S1473-3099(20)30477-1.v Hassan S., Hamlyn T., Fong H., Hampson G. 2026. The Value of Fast Diagnostics in Time-Critical Infections. OHE Contract Research Report, London: Office of Health Economicsvi U.S.
More news about: bioMérieux
Apr 20, 2026, 09:00 ET Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies
uses specially engineered lentiviral-based particles designed to efficiently and selectively enter T-cells inside the body, allowing the patient's own body to generate chimeric antigen receptor T-cell (CAR-T) therapies that can treat underlying disease. Kelonia's lead program, KLN-1010, is an investigational,
More news about: Eli Lilly and Company
Apr 20, 2026, 09:00 ET Ducati North America CEO Races 1971 Ducati 450 R/T Desmo at Biltwell 100
hardwareCustom-fabricated aluminum skid plateBespoke finishes inspired by the original 450 R/T Desmo prototype liveryChinnock competed aboard the 1971 Ducati 450 R/T Desmo in the Biltwell 100 Dual Shock (1971-1990) class with the goal of finishing. Despite fouling a plug on
More news about: Ducati North America
Apr 20, 2026, 09:00 ET MicroBit與HashKey聯手推動香港Web3生態：全港首座中本聰雕像於Web3嘉年華揭幕
照（證券交易）、第4類牌照（就證券提供意見）及第9類牌照（提供資產管理）受規管活動，並受證監會就虛擬資產基金經理（VAFM）所施加的額外條款及條件（「VAFM T&Cs」）所監管。了解更多詳情，可瀏覽公司網站：https://www.microbit.ai/zh-hant/。關於HashKey Holdings LimitedHashKey Holdings Limited (「HashKe
More news about: MicroBit Capital Management Limited